Literature DB >> 20544921

Diaphragm displays early and progressive functional deficits in dysferlin-deficient mice.

Elisabeth R Barton1, Bing Jing Wang, Becky K Brisson, H Lee Sweeney.   

Abstract

Mouse lines with dysferlin deficiency are accepted animal models for limb girdle muscular dystrophy 2B and Miyoshi myopathy, yet slow progression of pathology prevents rapid screening of potential therapies for this disease. Our goal was to define a functional signature for skeletal muscles that lack dysferlin. Force generation and susceptibility to eccentric contractile injury measurements were performed in isolated limb muscles and the diaphragm from 10- and 36-week-old A/J and age-matched control mice. Limb muscles had normal specific force at both 10 and 36 weeks, whereas the diaphragm had significant deficits in both specific force and susceptibility to eccentric contractile injury. Membrane ruptures in the diaphragm during eccentric contractions occurred predominantly in myosin heavy chain 2A-expressing fibers. Dysferlin content did not vary significantly between wildtype muscles, suggesting that there was no correlation between disease severity and normal endogenous levels of the protein. These studies show that, unlike limb muscles, the diaphragm from the A/J mouse displays early deficits in function that may lower the age needed for evaluating potential therapies for dysferlinopathies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20544921      PMCID: PMC4665095          DOI: 10.1002/mus.21645

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  20 in total

1.  Scaling of respiratory variables in mammals.

Authors:  W R Stahl
Journal:  J Appl Physiol       Date:  1967-03       Impact factor: 3.531

2.  Normal myoblast fusion requires myoferlin.

Authors:  Katherine R Doherty; Andrew Cave; Dawn Belt Davis; Anthony J Delmonte; Avery Posey; Judy U Earley; Michele Hadhazy; Elizabeth M McNally
Journal:  Development       Date:  2005-11-09       Impact factor: 6.868

3.  Impaired recovery of dysferlin-null skeletal muscle after contraction-induced injury in vivo.

Authors:  Joseph A Roche; Richard M Lovering; Robert J Bloch
Journal:  Neuroreport       Date:  2008-10-29       Impact factor: 1.837

4.  Small-caliber skeletal muscle fibers do not suffer deleterious consequences of dystrophic gene expression.

Authors:  G Karpati; S Carpenter
Journal:  Am J Med Genet       Date:  1986-12

5.  Adaptations in myosin heavy chain expression and contractile function in dystrophic mouse diaphragm.

Authors:  B J Petrof; H H Stedman; J B Shrager; J Eby; H L Sweeney; A M Kelly
Journal:  Am J Physiol       Date:  1993-09

6.  A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B.

Authors:  R Bashir; S Britton; T Strachan; S Keers; E Vafiadaki; M Lako; I Richard; S Marchand; N Bourg; Z Argov; M Sadeh; I Mahjneh; G Marconi; M R Passos-Bueno; E de S Moreira; M Zatz; J S Beckmann; K Bushby
Journal:  Nat Genet       Date:  1998-09       Impact factor: 38.330

7.  Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy.

Authors:  J Liu; M Aoki; I Illa; C Wu; M Fardeau; C Angelini; C Serrano; J A Urtizberea; F Hentati; M B Hamida; S Bohlega; E J Culper; A A Amato; K Bossie; J Oeltjen; K Bejaoui; D McKenna-Yasek; B A Hosler; E Schurr; K Arahata; P J de Jong; R H Brown
Journal:  Nat Genet       Date:  1998-09       Impact factor: 38.330

Review 8.  Molecular diversity of myofibrillar proteins: isoforms analysis at the protein and mRNA level.

Authors:  S Schiaffino; G Salviati
Journal:  Methods Cell Biol       Date:  1997       Impact factor: 1.441

9.  Dysferlin protein analysis in limb-girdle muscular dystrophies.

Authors:  M Vainzof; L V Anderson; E M McNally; D B Davis; G Faulkner; G Valle; E S Moreira; R C Pavanello; M R Passos-Bueno; M Zatz
Journal:  J Mol Neurosci       Date:  2001-08       Impact factor: 2.866

10.  Attenuated muscle regeneration is a key factor in dysferlin-deficient muscular dystrophy.

Authors:  Yen-Hui Chiu; Mark A Hornsey; Lars Klinge; Louise H Jørgensen; Steven H Laval; Richard Charlton; Rita Barresi; Volker Straub; Hanns Lochmüller; Kate Bushby
Journal:  Hum Mol Genet       Date:  2009-03-13       Impact factor: 6.150

View more
  18 in total

1.  Nonmuscle myosin IIA facilitates vesicle trafficking for MG53-mediated cell membrane repair.

Authors:  Peihui Lin; Hua Zhu; Chuanxi Cai; Xianhua Wang; Chunmei Cao; Ruiping Xiao; Zui Pan; Noah Weisleder; Hiroshi Takeshima; Jianjie Ma
Journal:  FASEB J       Date:  2012-01-17       Impact factor: 5.191

2.  Increased catalase expression improves muscle function in mdx mice.

Authors:  Joshua T Selsby
Journal:  Exp Physiol       Date:  2010-11-01       Impact factor: 2.969

3.  Increased nonHDL cholesterol levels cause muscle wasting and ambulatory dysfunction in the mouse model of LGMD2B.

Authors:  Stephanie L Sellers; Nadia Milad; Zoe White; Chris Pascoe; Rayleigh Chan; Geoffrey W Payne; Chun Seow; Fabio Rossi; Michael A Seidman; Pascal Bernatchez
Journal:  J Lipid Res       Date:  2017-11-25       Impact factor: 5.922

4.  Treatment with Recombinant Human MG53 Protein Increases Membrane Integrity in a Mouse Model of Limb Girdle Muscular Dystrophy 2B.

Authors:  Liubov V Gushchina; Sayak Bhattacharya; Kevin E McElhanon; Jin Hyuk Choi; Heather Manring; Eric X Beck; Jenna Alloush; Noah Weisleder
Journal:  Mol Ther       Date:  2017-07-03       Impact factor: 11.454

5.  Disease-modifying effects of orally bioavailable NF-κB inhibitors in dystrophin-deficient muscle.

Authors:  David W Hammers; Margaret M Sleeper; Sean C Forbes; Cora C Coker; Michael R Jirousek; Michael Zimmer; Glenn A Walter; H Lee Sweeney
Journal:  JCI Insight       Date:  2016-12-22

6.  Isometric and eccentric force generation assessment of skeletal muscles isolated from murine models of muscular dystrophies.

Authors:  Catherine Moorwood; Min Liu; Zuozhen Tian; Elisabeth R Barton
Journal:  J Vis Exp       Date:  2013-01-31       Impact factor: 1.355

7.  Dystrophin and utrophin expression require sarcospan: loss of α7 integrin exacerbates a newly discovered muscle phenotype in sarcospan-null mice.

Authors:  Jamie L Marshall; Eric Chou; Jennifer Oh; Allan Kwok; Dean J Burkin; Rachelle H Crosbie-Watson
Journal:  Hum Mol Genet       Date:  2012-07-13       Impact factor: 6.150

Review 8.  Skeletal muscle explants: ex-vivo models to study cellular behavior in a complex tissue environment.

Authors:  Lucas R Smith; Gretchen A Meyer
Journal:  Connect Tissue Res       Date:  2019-09-06       Impact factor: 3.417

Review 9.  Exploring the elephant: histopathology in high-throughput phenotyping of mutant mice.

Authors:  Paul N Schofield; Peter Vogel; Georgios V Gkoutos; John P Sundberg
Journal:  Dis Model Mech       Date:  2011-10-25       Impact factor: 5.758

10.  Lung- and Diaphragm-Protective Ventilation.

Authors:  Ewan C Goligher; Martin Dres; Bhakti K Patel; Sarina K Sahetya; Jeremy R Beitler; Irene Telias; Takeshi Yoshida; Katerina Vaporidi; Domenico Luca Grieco; Tom Schepens; Giacomo Grasselli; Savino Spadaro; Jose Dianti; Marcelo Amato; Giacomo Bellani; Alexandre Demoule; Eddy Fan; Niall D Ferguson; Dimitrios Georgopoulos; Claude Guérin; Robinder G Khemani; Franco Laghi; Alain Mercat; Francesco Mojoli; Coen A C Ottenheijm; Samir Jaber; Leo Heunks; Jordi Mancebo; Tommaso Mauri; Antonio Pesenti; Laurent Brochard
Journal:  Am J Respir Crit Care Med       Date:  2020-10-01       Impact factor: 30.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.